Analyst price target range
Ascendis Pharma Price Target: $304.85 Average
Direct answer
Ascendis Pharma's average price target is $304.85.
The verified analyst range runs from $261.17 to $342.43.
The low target implies +2.1%, the high target implies +33.9%, and the range spans 31.8% of the current price.
Forecast evidence checked November 10, 2026.
Get free Ascendis Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $255.75
- Average price target
- $304.85
- High price target
- $342.43
- Low price target
- $261.17
- Low target gap
- +2.1%
- Target upside
- +19.2%
- High target gap
- +33.9%
- Target range width
- 31.8%
- Consensus rating
- Strong Buy
- Analysts
- 21
- Evidence date
- November 10, 2026
- Valid through
- November 17, 2026
Explore related company data
Read the frequently asked questions.
What is Ascendis Pharma's average price target?
Ascendis Pharma's verified average price target is $304.85. The target range is $261.17 to $342.43.
How far are Ascendis Pharma's low and high targets from the recorded price?
The low target implies +2.1%, while the high target implies +33.9%.
How many analysts are included in Ascendis Pharma's consensus?
The verified consensus includes 21 analysts.
How is Ascendis Pharma's target upside or downside calculated?
The average target of $304.85 is divided by the recorded price of $255.75, then one is subtracted to produce +19.2%. This does not guarantee a future return.
When was Ascendis Pharma's analyst forecast verified?
The data was verified on 2026-11-10. The dataset is valid through 2026-11-17.